Effects of diarylsulfonylurea antitumor agents on the function of mitochondria isolated from rat liver and GC3/c1 cells.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Biochemical Pharmacology

• Publication date

  1992-12-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(92)90684-BPMID 1472104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for mitochondrial localization of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)urea in human colon adenocarcinoma cells.

  1990cited by this paper
• Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl)-urea.

  1990cited by this paper
• Phase I clinical study of N-[(4-chlorophenyl)amino]carbonyl-2,3-dihydro-1H-indene-5-sulfonamide (LY186641).

  1989cited by this paper
• The mechanism of acute cytotoxicity of triethylphosphine gold(I) complexes. III. Chlorotriethylphosphine gold(I)-induced alterations in isolated rat liver mitochondrial function.

  1989cited by this paper
• Safranine as membrane potential probe in rat liver mitochondria.

  1980cited by this paper
• Evaluation of single-agent therapy in human colorectal tumour xenografts.

  1978cited by this paper
• Safranine as a probe of the mitochondrial membrane potential

  1976cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Effects of ring substituents on the activity of phenols as inhibitors and uncouplers of mitochondrial respiration.

  1971cited by this paper
• [15] Isolation of liver or kidney mitochondria

  1967cited by this paper
• Methods in Enzymology , Vol

  1966cited by this paper

• Novel N-(aryl/heteroaryl)-2-chlorobenzenesulfonamide derivatives: Synthesis and anticancer activity evaluation.

  2020cites this paper
• ECTO-NOX Proteins

  2013cites this paper
• The Mitochondria Free Iron Content to Limit an Isotope Effect of 25Mg2+ in ATP Synthesis: A caution

  2013cites this paper
• The tissue-specific "ferromagnetic attack" on hyperactivation of ATP synthesis by magnesium-25 in mitochondria.

  2012cites this paper
• Cancer Therapeutic Applications of ENOX2 Proteins

  2012cites this paper
• 2-Anilinonicotinyl linked 2-aminobenzothiazoles and [1,2,4]triazolo[1,5-b] [1,2,4]benzothiadiazine conjugates as potential mitochondrial apoptotic inducers.

  2011cites this paper
• Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives

  2011cites this paper
• Synthesis and Biological Evaluation of Mercapto Triazolo‐Benzothiadiazine Linked Aminobenzothiazoles as Potential Anticancer Agents

  2009cites this paper
• Synthesis, DNA-binding ability and evaluation of antitumour activity of triazolo[1,2,4]benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.

  2008cites this paper
• Comparative cytotoxicity of alkyl gallates on mouse tumor cell lines and isolated rat hepatocytes.

  2007cites this paper
• 1,2,4-benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: synthesis, DNA-binding affinity and cytotoxicity.

  2007cites this paper
• A phase I study of sulofenur in refractory pediatric malignant solid tumors

  2007cites this paper
• Antitumor diarylsulfonylureas: novel agents with unfulfilled promise

  2004cites this paper
• Anticancer and antiviral sulfonamides.

  2003cites this paper
• Chemotherapeutics and Hormesis

  2003cites this paper
• Mitochondria as a Pharmacological Target

  2002cites this paper
• Sulfonamides and sulfonylated derivatives as anticancer agents.

  2002cites this paper
• Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line.

  2002influential citation
• Glutathione-dependent metabolism of the antitumor agent sulofenur. Evidence for the formation of p-chlorophenyl isocyanate as a reactive intermediate.

  2002cites this paper
• Induction of G(2)/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells.

  2001cites this paper
• Induction of G2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells

  2001cites this paper
• Novel sulphonamide derivatives for the treatment of cancer

  2000cites this paper
• Carbonic Anhydrase Inhibitors: Aromatic Sulfonamides and Disulfonamides Act as Efficient Tumor Growth Inhibitors

  2000cites this paper
• Mitochondrial targets of drug toxicity.

  2000cites this paper
• Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents.

  2000cites this paper
• 4-toluenesulfonylureido derivatives of amines, amino acids and dipeptides: a novel class of potential antitumor agents.

  2000cites this paper
• Pharmacology of CFTR chloride channel activity.

  1999cites this paper
• Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I.

  1999cites this paper
• Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action.

  1998cites this paper
• A Circulating Form of NADH Oxidase Activity Responsive to the Antitumor Sulfonylurea N-4-(methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984) Specific to Sera from Cancer Patients

  1997cites this paper
• A protein disulfide-thiol interchange activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984)

  1997cites this paper
• Inhibition of NADH oxidase activity and growth of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) and response to epidermal growth factor.

  1997cites this paper
• Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.

  1997cites this paper
• Separation of resistance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins.

  1996cites this paper
• H-ras transfection of the rat kidney cell line NRK-52E results in increased induction of c-fos, c-jun and hsp70 following sulofenur treatment.

  1996cites this paper
• Characterization of the intracellular distribution and binding in human adenocarcinoma cells of N-(4-azidophenylsulfonyl)-N'-(4-chlorophenyl)urea (LY219703), a photoaffinity analogue of the antitumor diarylsulfonylurea sulofenur.

  1995cites this paper
• Inhibition of the NADH oxidase activity of plasma membranes isolated from xenografts and cell lines by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY 181984) correlates with drug susceptibility of growth

  1995cites this paper
• HeLa plasma membranes bind the antitumor sulfonylurea LY181984 with high affinity.

  1995cites this paper
• Mechanism of killing of HeLa cells by the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY 181984)

  1995cites this paper
• Identification of antitumor sulfonylurea binding proteins of HeLa plasma membranes.

  1995cites this paper
• The antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'-(4-chlorophenyl) urea (LY181984) inhibits NADH oxidase activity of HeLa plasma membranes.

  1995cites this paper
• Response of NADH oxidation and growth in K-562 cells to the antitumor sulfonylurea, N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY181984)

  1995cites this paper
• Sulofenur cytotoxicity and changes in cytosolic calcium and mitochondrial membrane potential in human colon adenocarcinoma cell lines.

  1995cites this paper
• Proton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N'-(4-cholorophenyl) urea (LY181984).

  1995cites this paper
• Efficacy of sulofenur and a second generation diarylsulfonylurea, N‐[5‐(2,3‐dihydrobenzofuryl) sulfonyl]‐N'‐(3,4‐dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts

  1995cites this paper
• Golgi apparatus respond to the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY 181984) in sulfonylurea-susceptible but not in resistant cell lines

  1994cites this paper
• Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.

  1994cites this paper
• Effect of albumin on antitumor activity of diarylsulfonylureas.

  1993cites this paper